TNXP
Tonix Pharmaceuticals Holding Corp.
NASDAQ · USHealthcareBiotechnology
$10.98-11.67%
Price as of Jul 20, 2026
TNXP profitability
Tonix Pharmaceuticals Holding Corp. profitability
Margins, returns on capital and operating-efficiency metrics from the latest trailing period.
Margins
- Gross margin
- 52.6%
- EBITDA margin
- -828.2%
- EBIT margin
- -861.2%
- Net margin
- -839.5%
- Free cash flow margin
- -755.6%
Returns
- Return on equity
- -64.9%
- Return on assets
- -57.1%
- Return on invested capital
- -66.2%
- Asset turnover
- 0.07x
Cash efficiency
- Cash from operations
- -$125.6M
- Cash per share
- $12
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.